A Novel Prognostic Scoring System Integrating Gene Expressions and Clinicopathological Characteristics to Predict Very Early Relapse in Node-Negative Estrogen Receptor-Positive/HER2-Negative Breast Cancer

Background: Despite low aggressiveness in tumor biology and high responsiveness to endocrine therapy, subgroups of patients with estrogen receptor-positive/HER2-negative (ER+/HER2-) breast cancer relapse early in the first two years after initiation of endocrine therapy, indicating potential endocri...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Caijin, Wu, Jiayi, Lin, Lin, Fei, Xiaochun, Chen, Xiaosong, Huang, Ou, He, Jianrong, Chen, Weiguo, Li, Yafen, Shen, Kunwei, Zhu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518385/
https://www.ncbi.nlm.nih.gov/pubmed/33042787
http://dx.doi.org/10.3389/fonc.2020.01335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518385/
https://www.ncbi.nlm.nih.gov/pubmed/33042787
http://dx.doi.org/10.3389/fonc.2020.01335

Ejemplares similares